Your browser doesn't support javascript.
loading
Cognitive Function and Control of Type 2 Diabetes Mellitus in Young Adults.
Roy, Satyajeet; Kim, Nami; Desai, Anjali; Komaragiri, Mahathi; Baxi, Namrata; Jassil, Navinder; Blessinger, Megan; Khan, Maliha; Cole, Robert; Desai, Nayan; Terrigno, Rocco; Hunter, Krystal.
Afiliação
  • Roy S; Department of Medicine, Cooper University Hospital, Camden, New Jersey, USA.
  • Kim N; Department of Medicine, Cooper University Hospital, Camden, New Jersey, USA.
  • Desai A; Department of Medicine, Cooper University Hospital, Camden, New Jersey, USA.
  • Komaragiri M; Department of Medicine, Cooper University Hospital, Camden, New Jersey, USA.
  • Baxi N; Department of Medicine, Cooper University Hospital, Camden, New Jersey, USA.
  • Jassil N; Department of Medicine, Cooper University Hospital, Camden, New Jersey, USA.
  • Blessinger M; Department of Medicine, Cooper University Hospital, Camden, New Jersey, USA.
  • Khan M; Department of Medicine, Cooper University Hospital, Camden, New Jersey, USA.
  • Cole R; Department of Medicine, Cooper University Hospital, Camden, New Jersey, USA.
  • Desai N; Department of Medicine, Cooper University Hospital, Camden, New Jersey, USA.
  • Terrigno R; Department of Medicine, Cooper University Hospital, Camden, New Jersey, USA.
  • Hunter K; Cooper Research Institute, Cooper Medical School of Rowan University, Camden, New Jersey, USA.
N Am J Med Sci ; 7(5): 220-6, 2015 May.
Article em En | MEDLINE | ID: mdl-26110134
BACKGROUND: Type 2 diabetes mellitus (T2DM) has been associated with impairment of cognitive function. Studies show a strong negative correlation between the levels of glycosylated hemoglobin and cognitive function in adult patients above the mean age of 60 years. In healthy adults, age-related cognitive impairment is mostly reported after the age of 60 years, hence the decline in cognitive function can be a part of normal aging without diabetes. Since the majority of patients with diabetes are between the ages of 40 and 59 years, it is crucial to ascertain whether the levels of glycosylated hemoglobin negatively correlate with the levels of cognitive function scores in adult patients of age 60 years or younger, similar to the way it correlates in patients older than 60 years of age, or not. AIMS: We observed the relationship between the levels of glycosylated hemoglobin and the levels of cognitive function in patients of age 60 years or younger with T2DM. MATERIALS AND METHODS: Eighty-two patients with T2DM underwent cognitive assessment testing by using a Modified Mini-Mental State Examination (3MS), and their cognitive function scores were correlated with their glycosylated hemoglobin levels, durations of diabetes, and levels of education. RESULTS: Cognitive impairment was observed in 19.5% of the studied patients. We found a weakly negative relationship between the glycosylated hemoglobin level and cognitive function score (r = -0.292), a moderately negative relationship between the duration of diabetes and cognitive function score (r = -0.303), and a weakly positive relationship between the level of education and cognitive function score (r = 0.277). CONCLUSION: Cognitive impairment affects one-fifth of the patients of age 60 years or younger with T2DM. It is weakly negatively related to the glycosylated hemoglobin level, moderately negatively related to the duration of diabetes, and weakly positively related to the level of education.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2015 Tipo de documento: Article